Time to Talk about Actos?

October 28, 2012

Actos (pioglitazone) may have helped thousands of Americans, but it has also been a source of concern, conflict, and consternation for many patients, particularly consumers who have taken Actos, Actoplus Met, Duetact, and other pioglitazone-based drugs for longer than one year.

 

The Food and Drug Administration (FDA) has issued clear warnings in recent years that have underscored the very real potential hazards of extended pioglitazone-based treatments. Given the drug’s detriments as well as benefits, clear and effective labeling is important. Sadly, however, insufficient product information has left some patients making decisions that aren’t necessarily in their best interest.

 

Ready to talk to the dedicated attorneys and professionals at Fears Nachawati about whether Actos’s insufficient labeling may have violated your rights? We know how to give you the advice and perspective you need. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com. We’re ready to fight for you!

More Blog Posts

CONTACT US

Use the form below to send us a note, call us at 214.890.0711 or chat with us live. We are eager to help with all your legal needs. Please keep in mind that any unsolicited information sent through our website cannot be treated as confidential. Contacting us through this site does not create a representation relationship with Fears | Nachawati.

Inquiry Type

  • General
  • Personal Injury
  • Immigration
  • Bankruptcy
  • Drug Litigation
  • Family Law

Locations

With offices in Texas, Florida and Colorado and attorneys licensed in Texas, Florida, Colorado, Arkansas and Oklahoma, Fears | Nachawati is dedicated to attaining the best possible solutions for our clients’ business and personal needs. We strive to be professionals who are creative, empathetic and reliable.

All Areas Served

We Can Help

Contact Fears Nachawati today

Free Consulation

Live Chat (Online Now)